IDEAYA BIOSCIENCES ($IDYA) posted quarterly earnings results on Thursday, February 13th. The company reported earnings of -$1.49 per share, missing estimates of -$0.65 by $0.84. The company also reported revenue of $7,000,000, beating estimates of $4,760,085 by $2,239,915.
You can see Quiver Quantitative's $IDYA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IDEAYA BIOSCIENCES Hedge Fund Activity
We have seen 135 institutional investors add shares of IDEAYA BIOSCIENCES stock to their portfolio, and 87 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. added 1,347,252 shares (+inf%) to their portfolio in Q3 2024, for an estimated $42,680,943
- HOLOCENE ADVISORS, LP removed 1,309,025 shares (-69.9%) from their portfolio in Q3 2024, for an estimated $41,469,912
- JANUS HENDERSON GROUP PLC added 1,086,356 shares (+26.7%) to their portfolio in Q3 2024, for an estimated $34,415,758
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,085,000 shares (-52.5%) from their portfolio in Q3 2024, for an estimated $34,372,800
- GOLDMAN SACHS GROUP INC added 888,950 shares (+102.3%) to their portfolio in Q4 2024, for an estimated $22,846,015
- BLACKROCK, INC. added 696,115 shares (+9.1%) to their portfolio in Q4 2024, for an estimated $17,890,155
- POLAR CAPITAL HOLDINGS PLC added 655,000 shares (+inf%) to their portfolio in Q3 2024, for an estimated $20,750,400
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
